The BioCryst Pharmaceuticals Inc. (BCRX) Receives Consensus Rating of “Hold” from Brokerages

The biotechnology company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.26) by $0.04. The firm earned $4.80 million …

Advertisements
The BioCryst Pharmaceuticals Inc. (BCRX) Receives Consensus Rating of “Hold” from Brokerages

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s